[186 Pages Report] The Infection Surveillance Solution Market size was estimated at USD 768.47 million in 2023 and expected to reach USD 867.99 million in 2024, at a CAGR 13.36% to reach USD 1,849.73 million by 2030.

Infection surveillance solutions predict resident and healthcare staff infections in real-time and control possible epidemics. The solutions record infection data and turn it into actionable insights for strategic planning to prevent potential infections. The instances of hospital-acquired infections in adults grow the market. However, there is a need to employ cost-effective measures to adopt infection surveillance tools by small-scale laboratories and healthcare facilities. The ongoing innovations based on artificial intelligence and data analytics are improving the efficiency of infection surveillance solutions by combining them with electronic medical records.

Regional Insights

In the Americas, Government agencies such as the Centers for Disease Control and Prevention (CDC) manages infection surveillance through secure, internet-based surveillance systems of national healthcare safety networks. The increasing number of patients suffering from infectious diseases and the need for antimicrobial tracking surged the need for infection surveillance solutions in the market. The market players in the Americas are advancing innovative technologies for infection surveillance based on artificial intelligence and data science tools. Public and private sector is investing in research and development of innovative technologies in infection surveillance in the region.

The Middle East and Africa’s market is anticipated to boost due to growing healthcare sector in the region. The Asia-Pacific region is expected to raise the market demand due to the increasing number of healthcare facilities. The growing awareness about antimicrobial resistance and hospital-acquired infections is the rising adoption of infection surveillance solutions in the region.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Infection Surveillance Solution Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Infection Surveillance Solution Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Infection Surveillance Solution Market, highlighting leading vendors and their innovative profiles. These include 3M Company, Altarum, Baxter International, Inc., Becton, Dickinson and Company, bioM?rieux SA, BioVigil Healthcare Systems, Inc., Cardinal Health Inc., CenTrak, Inc., Clinsys, Inc., Conduent, Inc., Datlowe, s.r.o., DNV AS, Ecolab Inc., Gunnebo Entrance Control Ltd., Health Matrix., Ibhar Technologies Pvt Ltd, Inovalon, International Business Machines Corporation, Medexter Healthcare GmbH, Oracle Corporation, PointClickCare, Premier Inc., RLDatix, Securitas Healthcare, LLC., Strategic Solutions Group, Thermo Fisher Scientific Inc., Vecna Technologies, Inc., VigiLanz Corporation, Vitalacy Inc., Vizzia Technologies, and Wolters Kluwer N.V..

Market Segmentation & Coverage

This research report categorizes the Infection Surveillance Solution Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Product
    • Services
      • Implementation Services
      • Product Support & Maintainnace Services
      • Training & Consulting Services
    • Software
      • Antimicrobial Monitoring & Control
      • Infection Surveillance
        • Laboratory surveillance
        • Surgical surveillance & patient monitoring
      • Outbreak Management
        • Isolation Management
        • Potential Outbreak Alert
      • Staff Health & Compliance
  • Deployment
    • On-Cloud
    • On-Premise
  • End-User
    • Hospital
    • Laboratories
    • Long-Term Care Facility

  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

  1. Market Penetration: It presents comprehensive information on the market provided by key players.
  2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
  3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
  4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
  5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

  1. What is the market size and forecast of the Infection Surveillance Solution Market?
  2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Infection Surveillance Solution Market?
  3. What are the technology trends and regulatory frameworks in the Infection Surveillance Solution Market?
  4. What is the market share of the leading vendors in the Infection Surveillance Solution Market?
  5. Which modes and strategic moves are suitable for entering the Infection Surveillance Solution Market?